Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

CVS Health Corporation (CVS) had Revenue of $105.69B for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$105.69B
Net Income	$2.94B
Cost of Goods Sold	$59.06B
Gross Profit	$46.63B
Operating Expenses	$103.58B
Operating Income	$2.11B
Non-Operating Income/Expense	$-758.00M
Pre-Tax Income	$1.35B
Normalized Pre-Tax Income	$1.35B
Income after Taxes	$2.92B
Income from Continuous Operations	$2.92B
Consolidated Net Income/Loss	$2.92B
Normalized Income after Taxes	$2.92B
EBIT	$2.11B
EBITDA	$3.26B
Weighted-Average Shares Outstanding (Basic)	1.27B
Weighted-Average Shares Outstanding (Diluted)	1.27B
Earnings per Share (EPS) (Basic)	$2.31
Earnings per Share (EPS) (Diluted)	$2.31
Balance Sheet Financials
Current Assets	$74.71B
Property, Plant, and Equipment	$13.08B
Long-Term Assets	$178.82B
Total Assets	$253.54B
Current Liabilities	$88.69B
Long-Term Debt	$60.50B
Long-Term Liabilities	$89.46B
Total Liabilities	$178.16B
Common Equity	$75.38B
Tangible Shareholders Equity	$-35.60B
Shareholders Equity	$75.38B
Common Shares Outstanding	1.27B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$10.64B
Cash Flow from Investing Activities	$-5.87B
Cash Flow from Financial Activities	$-4.94B
Beginning Cash	$8.88B
End Cash	$8.71B
Increase/Decrease in Cash	$-172.00M
Stock-Based Compensation	$535.00M
Common Stock Dividends Paid	$-3.40B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.84
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.45
Debt to Equity Ratio	0.86
Gross Margin	44.12%
Operating Margin	2.00%
EBIT Margin	2.00%
EBITDA Margin	--
Pre-Tax Profit Margin	1.28%
Profit Margin	2.78%
Free Cash Flow	$7.81B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.42
Inventory Turnover	3.07
Receiveable Turnover	2.66
Days Sales in Receivables	33.87
Return on Equity	3.88%
Return on Tangible Equity	-8.21%
Return on Assets	1.15%
Return on Investments	2.15%
Book Value Per Share	$59.31
Free Cash Flow per Share	$6.14
Operating Cash Flow per Share	$8.37

Data from Zacks Investment Research, Inc.